Registration |Ballroom Gallery

Lunch |Foyer ABC

Sponsored by  

Opening Remarks |Ballroom ABC

Healthcare Distribution Through the Executive Lens |Ballroom ABC

Hear from a panel of pharmaceutical supply chain executives as they discuss the challenges and opportunities for distributors around the world. Learn about the current evolution of European and U.S. business models and how they respond to unique disruption challenges. This executive panel also will identify the trends that are dynamically shaping the industry.

	Greg Drew, RPh, President, Value Drug Company
	Jon L. Giacomin, Chief Executive Officer, Medical Segment, Cardinal Health, Inc.
	John M. Gray, President and CEO, Healthcare Distribution Alliance
	Kaspar Niklaus, Managing Director, Amedis-UE AG
	Alicia Wildpret Zugaza, PhD, Chief Financial Officer, Cofares

Networking Break |Foyer ABC

Fighting Falsified Medicines: Implementing Medicines Verification Initiatives |Ballroom ABC

Senior supply chain executives will review the operational impact of implementing regulations to trace or verify medicines in the EU and the U.S.

	Ronan Brett, Group Public Affairs Director, McKesson Europe AG
	John Quentin Dittman, Director, Sustain and Track & Trace, Cardinal Health, Inc.
	Perry L. Fri, Executive Vice President, Industry Relations, Membership & Education and COO, HDA Research Foundation, Healthcare Distribution Alliance
	Pablo Medina, Associate Director, Product Protection & Commercial Serialization, Genentech, A Member of the Roche Group
	Andreas M. Walter, General Manager, European Medicines Verification Organisation (EMVO)

Update on the Supply Chain Strategy Within Gavi |Ballroom ABC

Hear about how Gavi, a global Vaccine Alliance, has been supporting countries to improve immunization delivery systems. The increased focus on and investments in strengthening supply chains make it possible not only to reach more people who currently miss out on immunization services, but to do so with a full set of safe and viable vaccines.

Jeffrey Rowland, Director, Global Operational Partnerships, Gavi, the Vaccine Alliance

Maintaining Collaborative Supply Chain Partnerships |Ballroom ABC

This session will describe the characteristics of high-value supply chain trading partner relationships in the U.S. and in Europe. Hear about how goals and challenges are articulated in the relationships, as well as how they have developed over time — including the introduction of fee-for-service models.

	Jason A. Hanks, President of Commercial Operations, Granules Pharmaceuticals
	Scott Hussey, Senior Vice President, Global Sales, Upsher-Smith Laboratories, LLC
	Douglas M. Long, Vice President, Industry Relations, IQVIA
	Fabian Vaucher, President, pharmaSuisse (Swiss Association of Pharmacists)

Reception |FloorTwo Bar

Registration |Ballroom Gallery

Breakfast |Il Vero

What’s In, What’s Out, What’s Ahead: Healthcare Marketplace Trends |Ballroom ABC

Specializing in analyzing information from QuintilesIMS' premier sales, prescription, promotional and medical databases, industry experts will review the latest industry data and emerging market trends for branded and generic pharmaceutical and health and beauty care product sales. They will offer their perspectives on a range of vital pharmaceutical topics, including global market trends, industry forecasts, research and development, marketing practices, blockbuster drugs, patent expirations and generic trends, biotechnology and more. They also will analyze how emerging trends will affect strategic business plans in the coming year and beyond.

	Douglas M. Long, Vice President, Industry Relations, IQVIA
	Per Troein, Vice President, Strategic Partners, IQVIA

Biosimilars Update |Ballroom ABC

Hear about the current state and future of biosimilars around the globe. The session also will discuss the impact of biosimilars on healthcare costs, patient access, as well as challenges that still exist for developing and bringing biosimilars to market.

Maggie Dolan, Specialist Procurement Pharmacist, NHS Commercial Solutions

Networking Break |Foyer ABC

Value-Based Care |Ballroom ABC

Value-based care means getting more for the healthcare dollar, an issue that resonates globally. In the U.S., a whole new set of payment systems are rolling out, putting pressure on manufacturers and distributors to lower costs and show the value of their products and services. This session will describe the new models, challenges in changing today’s business models and point to strategies for success.

Sarah Thomas, MS, Managing Director, Deloitte Center for Health Solutions

Lunch |Foyer ABC

Sponsored by  

Protecting the Global Pharmaceutical Supply Chain |Ballroom ABC

This session will examine issues related to global, Internet-based pharmaceutical crime — and what governments and organizations can do to stop this type of abuse. In addition to describing the scope of this problem and the incidents observed by law enforcement, the session also will cover the use of social media as a marketing tool, as well as current and future security trends.

Stephen Truick, Director, Internet Infrastructure Investigation Ltd

Worldwide Challenges with Drug Shortages |Ballroom ABC

Significant shortages of commonly used drugs started to appear about 15 years ago, and now occur regularly in many countries and markets. This presentation will describe the scope of the problem, reasons for shortages, and how the shortages are being managed so that the impact on patients is minimized. Findings and recommendations from both the World Health Organization and the International Pharmaceutical Federation also will be presented.

Douglas J. Scheckelhoff, FASHP,RPh,MS, Senior Vice President, Office of Practice Advancement, American Society of Health-System Pharmacists (ASHP)

Global Politics and Health Policy |Ballroom ABC

Take an international tour of how changing politics are influencing healthcare policy.

	Fumie Griego, Ph.D., Assistant Director General, International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
	Patrick M. Kelly, Executive Vice President, Government Affairs, Healthcare Distribution Alliance

Adjournment